HeMemics Overview

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $4.5M

  • Investors
  • 5

HeMemics General Information

Description

Developer of a biosensor company designed to bring handheld, lab-quality testing performance wherever needed. The company's platform consists of a low-cost, handheld reader and a disposable biosensor that contains up to thirty-two pathogens using patented desiccation technology, enabling clients with the tools required for prompt and informed decision-making, and fostering a safer, healthier world.

Contact Information

Website
www.hememics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 401 Professional Drive
  • Suite 220
  • Gaithersburg, MD 20879-3445
  • United States
+1 (240)
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Nanotechnology, Digital Health, AgTech, HealthTech, Life Sciences
Corporate Office
  • 401 Professional Drive
  • Suite 220
  • Gaithersburg, MD 20879-3445
  • United States
+1 (240)

HeMemics Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HeMemics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Seed Round 05-Sep-2023 $4.5M Completed Product Development
8. Seed Round 25-May-2023 Completed Product Development
7. Secondary Transaction - Private Completed Product Development
6. Seed Round 31-Dec-2020 Completed Product Development
5. Seed Round 09-Nov-2018 Completed Product Development
4. Angel (individual) 25-May-2018 Completed Startup
3. Seed Round 18-Dec-2017 Completed Startup
2. Accelerator/Incubator 01-Dec-2017 Completed Startup
1. Grant 01-Jan-2012 $185K Completed Startup
To view HeMemics’s complete valuation and funding history, request access »

HeMemics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed 2
Seed 1
To view HeMemics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

HeMemics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biosensor company designed to bring handheld, lab-quality testing performance wherever needed. The compan
Diagnostic Equipment
Gaithersburg, MD
10 As of 2025

Salt Lake City, UT
 

Saint Paul, MN
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

HeMemics Competitors (5)

One of HeMemics’s 5 competitors is Co-Diagnostics, a Formerly VC-backed company based in Salt Lake City, UT.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Co-Diagnostics Formerly VC-backed Salt Lake City, UT
Grip Molecular Venture Capital-Backed Saint Paul, MN
Lucira Health Formerly VC-backed Emeryville, CA
GrapheneDx Private Equity-Backed Boston, MA
Orasure Technologies Corporate Backed or Acquired Bethlehem, PA
You’re viewing 5 of 5 competitors. Get the full list »

HeMemics Patents

  • 24

    Total Documents Applications and Grants

  • Total Patents Families

  • 6

    Granted

  • 5

    Pending

  • Expiring in next 12 mo

HeMemics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4526680-A2 Multiplex biosensor for rapid point-of-care diagnostics Pending 16-May-2022
EP-4150331-A1 Multiplex biosensor for rapid point-of-care diagnostics Pending 15-May-2020
EP-4150331-A4 Multiplex biosensor for rapid point-of-care diagnostics Pending 15-May-2020
US-20230194520-A1 Multiplex biosensor for rapid point-of-care diagnostics Pending 15-May-2020
EP-3861330-A1 Biosensors using carbon nanotubes and an electronic reader for use with the biosensors Inactive 05-Oct-2018 G01N27/4146
To view HeMemics’s complete patent history, request access »

HeMemics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HeMemics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
DMV Angel Group Angel Group Minority
TEDCO Venture Capital Minority
American Vietnamese Investment Partners Venture Capital Minority
Inova Health System Corporation Minority
U.S. Department of Health and Human Services Government
To view HeMemics’s complete investors history, request access »

Ready to get started?

Request a free trial

HeMemics FAQs

  • Where is HeMemics headquartered?

    HeMemics is headquartered in Gaithersburg, MD.

  • What is the size of HeMemics?

    HeMemics has 10 total employees.

  • What industry is HeMemics in?

    HeMemics’s primary industry is Diagnostic Equipment.

  • Is HeMemics a private or public company?

    HeMemics is a Private company.

  • What is HeMemics’s current revenue?

    The current revenue for HeMemics is .

  • How much funding has HeMemics raised over time?

    HeMemics has raised $10.2M.

  • Who are HeMemics’s investors?

    DMV Angel Group, TEDCO, American Vietnamese Investment Partners, Inova Health System, and U.S. Department of Health and Human Services have invested in HeMemics.

  • Who are HeMemics’s competitors?

    Co-Diagnostics, Grip Molecular, Lucira Health, GrapheneDx, and Orasure Technologies are competitors of HeMemics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »